Shares of Twenty One Capital (XXI) rose 3.15% in pre-market trading after Tether International acquired SoftBank Group's ownership stake in the company, strengthening Tether's control. This ownership change led to SoftBank's board members resigning, marking SoftBank's full exit from XXI. The company is focusing on building a comprehensive Bitcoin ecosystem that includes treasury management, financial products, mining, lending, and capital markets. Despite the recent stock gain, XXI faces challenges with an 84% share price drop over the past year and ongoing losses, highlighting the need for investors to watch its development closely as it aims for sustainable revenue and Bitcoin accumulation.
The FDA has accepted ImmunityBio's supplemental Biologics License Application (sBLA) for ANKTIVA to treat BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). This acceptance marks a key advancement for the company, with a PDUFA action date s...
Avaí Bio and Austrianova have completed a Master Cell Bank (MCB) of genetically modified cells that overexpress the α-Klotho protein, a key anti-aging protein. This milestone is crucial for producing consistent, safe cell-based therapies targeting ag...
The IT and digital infrastructure market is rapidly expanding due to increased enterprise spending on cloud computing, AI integration, cybersecurity, and managed services. The U.S. IT services market alone reached $405.7 billion in 2023 and is projec...
OpenAI and Google have significantly increased their AI investments in Singapore, establishing the city-state as a key AI hub in Asia-Pacific. OpenAI opened its first applied AI lab outside the U.S. in Singapore, backed by a S$300 million commitment,...
Holzer & Holzer, LLC announced approaching deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Vital Farms, Super Micro Computer, and Aldeyra Therapeutics. These lawsuits allege misleading statements or ...
